ArticleHypertension (Dallas, Tex. : 1979)2017
Angiotensin II Type 2 Receptor and Receptor Mas Are Colocalized and Functionally Interdependent in Obese Zucker Rat Kidney.
Open access · bronzeAbstract read
In one paragraph
Article in Hypertension (Dallas, Tex. : 1979), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 53 citations in OpenAlex.
- Angiotensin-(1-7) Alleviates Isoproterenol-Induced Cardiac Hypertrophy by Suppressing Autophagy and Apoptosis Through the Synergistic Action of Mas Receptor and Angiotensin II Type 2 Receptor.Acta physiologica (Oxford, England) · 2026Article
- GPCR dimerization: Drug discovery aspects and targets in renin-angiotensin systems.FASEB bioAdvances · 2025Review
- Role of G-protein-coupled receptor kinase 4 on the dysfunction of renal Mas receptor in hypertension.PloS one · 2025Article
- RAAS in diabetic retinopathy: mechanisms and therapies.Archives of endocrinology and metabolism · 2024Review
- Angiotensin-II type 2 receptor-mediated renoprotection is independent of receptor Mas in obese Zucker rats fed high-sodium diet.Frontiers in pharmacology · 2024Article
- Eukaryotic elongation factor 2 kinase inhibitor, A484954 induced diuresis via nitric oxide production in spontaneously hypertensive rats.The Journal of veterinary medical science · 2023Article
- The alternative renin-angiotensin system in critically ill patients: pathophysiology and therapeutic implications.Critical care (London, England) · 2023Review
- The ATMolecules (Basel, Switzerland) · 2023Review
- Angiotensin II Type 1 Receptor Blocker Prevents Abdominal Aortic Aneurysm Progression in Osteoprotegerin-Deficient Mice via Upregulation of Angiotensin (1-7).Journal of the American Heart Association · 2023Article
- How Effective is Angiotensin II in Decreasing Mortality of Vasodilatory Shock? A Systematic Review.Open access emergency medicine : OAEM · 2023Review
- The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice.International journal of molecular sciences · 2022Article
- The Angiotensin ATPharmacological reviews · 2022Review
- Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting.Pharmacological reviews · 2022Review
- Relationship between ENaC Regulators and SARS-CoV-2 Virus Receptor (ACE2) Expression in Cultured Adult Human Fungiform (HBO) Taste Cells.Nutrients · 2022Article
- Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling.Hypertension (Dallas, Tex. : 1979) · 2021Review
- Angiotensin-(1-7)-A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic.Journal of clinical medicine · 2021Review
- ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease.Clinical science (London, England : 1979) · 2021Review
- Sex Differences in the Renal Vascular Responses of ATInternational journal of hypertension · 2021Article
- Synergism between Angiotensin receptors ligands: Role of Angiotensin-(1-7) in modulating ATPharmacology research & perspectives · 2020Article
- Angiotensin-(1-7) mitigated angiotensin II-induced abdominal aortic aneurysms in apolipoprotein E-knockout mice.British journal of pharmacology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Sanket N PatelFrom the Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, TX (S.N.P., Q.A., P.S., T.H.); and Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense (U.M.S.).
Quaisar AliFrom the Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, TX (S.N.P., Q.A., P.S., T.H.); and Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense (U.M.S.).
Preethi SamuelFrom the Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, TX (S.N.P., Q.A., P.S., T.H.); and Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense (U.M.S.).
Ulrike Muscha SteckelingsFrom the Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, TX (S.N.P., Q.A., P.S., T.H.); and Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense (U.M.S.).
Tahir HussainFrom the Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, TX (S.N.P., Q.A., P.S., T.H.); and Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense (U.M.S.). thussain@central.uh.edu.
University of Southern Denmark · DK
Funding
Renal Angiotensin ll Receptor Function in ObesityR01DK061578 · NIDDK · UNIVERSITY OF HOUSTON · PI HUSSAIN, TAHIR · 2003 to 2020
$4.3MNIDDK NIH HHS R01 DK061578
Abstract
The actions of angiotensin II type 2 receptor (AT
Indexed as
Blood PressureKidneyNatriuresisObesityProto-Oncogene MasAngiotensin IIAngiotensin II Type 1 Receptor BlockersAngiotensin II Type 2 Receptor BlockersAnimalsImidazolesKidney Tubules, ProximalMembrane ProteinsNitric OxidePeptide FragmentsPyridinesRats7-Ala-angiotensin (1-7)Angiotensin IIAngiotensin II Type 1 Receptor BlockersAngiotensin II Type 2 Receptor BlockersImidazolesMembrane ProteinsNitric OxidePD 123319Peptide FragmentsProto-Oncogene MasPyridinesReceptor, Angiotensin, Type 2Receptors, G-Protein-CoupledVasoconstrictor Agentsangiotensin-II type 2 receptorco-immunoprecipitationcolocalizationnatriuresisobese Zucker ratreceptor Masrenal epithelial cells
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.